Literature DB >> 9195948

Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B.

T A Berkhout1, H M Sarau, K Moores, J R White, N Elshourbagy, E Appelbaum, R J Reape, M Brawner, J Makwana, J J Foley, D B Schmidt, C Imburgia, D McNulty, J Matthews, K O'Donnell, D O'Shannessy, M Scott, P H Groot, C Macphee.   

Abstract

Here we describe the characterization of a novel human CC chemokine, tentatively named monocyte chemotactic protein (MCP-4). This chemokine was detected by random sequencing of expressed sequence tags in cDNA libraries. The full-length cDNA revealed an open reading frame for a 98-amino acid residue protein, and a sequence alignment with known CC chemokines showed high levels of similarity (59-62%) with MCP-1, MCP-3, and eotaxin. MCP-4 cDNA was cloned into Drosophila S2 cells, and the mature protein (residues 24-98) was purified from the conditioned medium. Recombinant MCP-4 induced a potent chemotactic response (EC50 = 2.88 +/- 0.15 nM) and a transient rise in cytosolic calcium concentration in fresh human peripheral blood monocytes but not in neutrophils. Binding studies in monocytes showed that MCP-4 and MCP-3 were very potent in displacing high affinity binding of 125I-MCP-1 (IC50 for MCP-4, MCP-3, and unlabeled MCP-1 of 2.1 +/- 1.4, 0.85-1.6, and 0.7 +/- 0.2 nM respectively), suggesting that all three chemokines interact with the CC chemokine receptor-2 (MCP-1 receptor). This was confirmed in binding studies with Chinese hamster ovary cells, stably transfected with the CC chemokine 2B receptor. Northern blot analysis in extracts of normal human tissues showed expression of mRNA for MCP-4 in small intestine, thymus, and colon, but the level of protein expression was too low to be detected in Western blot analysis. However, expression of MCP-4 protein was demonstrated by immunohistochemistry in human atherosclerotic lesion and found to be associated with endothelial cells and macrophages.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9195948     DOI: 10.1074/jbc.272.26.16404

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 2.  Interleukin-8 and its receptor CXCR2 in atherosclerosis.

Authors:  W A Boisvert; L K Curtiss; R A Terkeltaub
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

3.  Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells.

Authors:  F Mach; A Sauty; A S Iarossi; G K Sukhova; K Neote; P Libby; A D Luster
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

Review 4.  The role of chemokines in atherosclerosis.

Authors:  F Mach
Journal:  Curr Atheroscler Rep       Date:  2001-05       Impact factor: 5.113

5.  Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques.

Authors:  T J Reape; K Rayner; C D Manning; A N Gee; M S Barnette; K G Burnand; P H Groot
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

6.  Antimicrobial chemokines.

Authors:  Sunny C Yung; Philip M Murphy
Journal:  Front Immunol       Date:  2012-09-11       Impact factor: 7.561

7.  Detection of human MCP-4/CCL13 isoforms by SELDI immunoaffinity capture.

Authors:  Leonardo Rossi; Ramy Moharram; Brian M Martin; Richard L White; Monica C Panelli
Journal:  J Transl Med       Date:  2006-01-24       Impact factor: 5.531

Review 8.  The Role of CC-Chemokines in the Regulation of Angiogenesis.

Authors:  Anisyah Ridiandries; Joanne T M Tan; Christina A Bursill
Journal:  Int J Mol Sci       Date:  2016-11-08       Impact factor: 5.923

9.  Deletion of MCP-1 Impedes Pathogenesis of Acid Ceramidase Deficiency.

Authors:  Fabian P S Yu; Shaalee Dworski; Jeffrey A Medin
Journal:  Sci Rep       Date:  2018-01-29       Impact factor: 4.379

10.  CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function.

Authors:  R Mariani; S Wong; L C Mulder; D A Wilkinson; A L Reinhart; G LaRosa; R Nibbs; T R O'Brien; N L Michael; R I Connor; M Macdonald; M Busch; R A Koup; N R Landau
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.